Safeguard Scientifics (SFE) Announces 2009 Q3 Financial Results

Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6M, or $0.57 per share, compared with a net loss of $4.1M, or $0.20 per share, in the same period of 2008.

Third quarter results reflect a loss of $7.3M on the sale of 18.4M shares in Safeguard’s partner company Clarient, Inc., a cancer diagnostic services provider, based on net proceeds received compared to the market value at the end of the second quarter.

Safeguard Scientifics, Inc. (SFE) provides growth capital for entrepreneurial and innovative life sciences and technology companies.